If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Get Updates
609
Followers on Owler
CytomX
is an early-stage biotechnology company that develops antibody based therapeutics for the treatment of cancer and inflammatory diseases...
Read more
Overview
Competitors
Acquisitions
Funding
News & Insights
CytomX
is an early-stage biotechnology company that develops antibody based therapeutics for the treatment of cancer and inflammatory diseases...
Read more
Chairman & CEO
Sean A. McCarthy
CEO Approval Rating
88/100
Weigh In
2008
South San Francisco
California
San Francisco Bay Area
Public
NASDAQ
CTMX
Pharmaceuticals & Biotechnology
Biotechnology
2836
NAICS listing
https://cytomx.com/
Annual Revenue
$138.1M
Employees
170
Funding
$320.6M
Acquisitions
1
News
Key Events
Latest News
Conference Presentation
Mar 05, 2025
Marketscreener
CytomX Therapeutics to Present at the Barclays 27th Annual Global Healthcare Conference
Layoffs
Jan 07, 2025
BioSpace
CytomX to Cut 40% of Staff as It Updates Pipeline Priorities
Follow and Get Alerts
CytomX Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 12 + competitors
Trending Companies
